Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Brain Neoplasms × Watchful Waiting × Clear all

Phase

Status

Recruiting 2 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Thyroid Nodule 1 Thyroid Diseases 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Papillomavirus Infections 1 Oropharyngeal Neoplasms 1 Muscle-invasive Bladder Cancer 1 Mouth Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1

Interventions

aflutinib 3 Radiotherapy 3 Blood Specimen Collection 3 Bevacizumab 3 Surveys and Questionnaires 2 Radiosurgery 2 Magnetic Resonance Spectroscopy 2 Indocyanine Green 2 Cyclophosphamide 2 Biopsy 2 Aminolevulinic Acid 2 trastuzumab deruxtecan 1 tovorafenib 1 sacituzumab govitecan 1 posaconazole 1 pembrolizumab 1 peginterferon alfa-2b 1 osimertinib 1 neratinib 1 montelukast 1 lorlatinib 1 gallium maltolate 1 fludarabine 1 contrast agent BR1 1 asciminib 1 anlotinib 1 Watchful Waiting 1 Vitamin B 6 1 Valganciclovir 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06974370 2025-05-15

ACTION-Brain

University of Vermont Medical Center

Phase 2 Not yet recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡